Hundreds of thousands of Ebola vaccines to be ready in 2015: WHO

Image
IANS Geneva
Last Updated : Oct 24 2014 | 10:05 PM IST

Assistant Director-General of World Health Organisation (WHO) Marie-Paule Kieny Friday said hundreds of thousands of Ebola vaccines might be ready for use in the first half of 2015 to turn the tide against the deadly epidemic.

On Thursday, WHO convened a meeting of government representatives, vaccine manufacturers, funding agencies and civil society to discuss how to quicken the testing and deployment of promising vaccines in sufficient numbers to use in the field in 2015.

"Phase 1 of clinical trials of two most advanced vaccines have been started, the result of these trials will be available in December 2014," Kieny told a press conference at WHO's headquarters in Geneva.

Kieny said the trials of the two vaccines, cAd3-ZEBOV and rVSV-ZEBOV, developed by GlaxoSmithKline and Public Health Agency of Canada respectively, have begun in Britain, the US and Mali, and will shortly begin in Switzerland, Germany, Gabon and Kenya, Xinhua reported.

She noted that at least five more vaccines are following up closely, which will be in the clinic in the first month of 2015.

She said pharmaceutical companies that are developing the vaccines are committed to increasing the production capacity to millions of doses in 2015, with hundreds of thousands ready in the first half of next year.

"To make this a reality, regulatory authorities in countries where vaccines are being manufactured and in Africa will need to work closely with manufacturers, to extremely shorten timelines and to find ways to overcome the number of furthers," she added.

"Vaccines are not a magic bullet, but when ready they may be a good part of the effort to turn the tide against the epidemic," she said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 24 2014 | 10:02 PM IST

Next Story